Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia

NCT02517866 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
380
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda